- Home
- ECOR vs UCL Comparison
ECOR vs UCL Comparison
Compare ECOR & UCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ECOR
- UCL
- Stock Information
- Founded
- ECOR 2005
- UCL 2014
- Country
- ECOR United States
- UCL Hong Kong
- Employees
- ECOR N/A
- UCL N/A
- Industry
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- UCL Telecommunications Equipment
- Sector
- ECOR Health Care
- UCL Consumer Discretionary
- Exchange
- ECOR Nasdaq
- UCL Nasdaq
- Market Cap
- ECOR 57.5M
- UCL 49.7M
- IPO Year
- ECOR 2018
- UCL 2020
- Fundamental
- Price
- ECOR $6.69
- UCL $1.23
- Analyst Decision
- ECOR Strong Buy
- UCL
- Analyst Count
- ECOR 2
- UCL 0
- Target Price
- ECOR $25.50
- UCL N/A
- AVG Volume (30 Days)
- ECOR 216.5K
- UCL 46.6K
- Earning Date
- ECOR 03-12-2025
- UCL 03-13-2025
- Dividend Yield
- ECOR N/A
- UCL N/A
- EPS Growth
- ECOR N/A
- UCL 60.16
- EPS
- ECOR N/A
- UCL 0.12
- Revenue
- ECOR $25,182,000.00
- UCL $91,635,000.00
- Revenue This Year
- ECOR $40.88
- UCL $15.19
- Revenue Next Year
- ECOR $48.01
- UCL N/A
- P/E Ratio
- ECOR N/A
- UCL $10.32
- Revenue Growth
- ECOR 57.09
- UCL 7.08
- 52 Week Low
- ECOR $5.32
- UCL $0.97
- 52 Week High
- ECOR $19.49
- UCL $3.30
- Technical
- Relative Strength Index (RSI)
- ECOR 19.00
- UCL 45.63
- Support Level
- ECOR $6.57
- UCL $1.20
- Resistance Level
- ECOR $8.25
- UCL $1.39
- Average True Range (ATR)
- ECOR 0.92
- UCL 0.06
- MACD
- ECOR -0.15
- UCL 0.00
- Stochastic Oscillator
- ECOR 4.82
- UCL 20.00
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
About UCL uCloudlink Group Inc.
Ucloudlink Group Inc provides mobile data connectivity and portable WiFi services. The business operates under uCloudlink 1.0, which focuses on cross-border travelers that need mobile data connectivity services across different countries. Under uCloudlink 2.0, provides mobile data connectivity services to local users across different MNOs in a single country. It generates revenue from the provision of data connectivity services, and the sales of terminals and sales of data related products.